SCHEMBL6180402

SCHEMBL6180402

CS(=O)(=O)NC(=O)c1cccc(NC(=O)NC2CN(c3ccccc3)c3ccccc3N(CC(F)(F)F)C2=O)c1

nearest known ligand 0.51

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
CCKBR P32239 18/20 0.51
CCKAR P32238 3/20 0.41
FPR2 P25090 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6179674 0.90 CCKBR (0.55) CCKBRCCKAR
SCHEMBL6179955 0.88 CCKBR (0.56) CCKBRCCKAR
SCHEMBL6179120 0.88 CCKBR (0.50) CCKBRCCKAR
SCHEMBL6179233 0.87 CCKBR (0.68) CCKBR
SCHEMBL6179489 0.86 CCKBR (0.54) CCKBR
SCHEMBL6178201 0.85 CCKBR (0.48) CCKBRCCKAR
SCHEMBL6176396 0.85 CCKBR (0.52) CCKBRCCKAR
SCHEMBL6179418 0.85 CCKBR (0.51) CCKBRCCKAR
SCHEMBL6179676 0.83 CCKBR (0.49) CCKBRCCKAR
SCHEMBL6177526 0.77 CCKBR (0.52) CCKBRCCKAR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 EP disclosed